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This chapter represents advanced scientific exploration in the different 
disciplines of SCD and channelopathy. Epidemiology of SCD and channelopathy 
is given special attention. The essence of detailed electrophysiological bases of the 
different diseases of channelopathies and the diverse cellular pathways mandated 
detailed discussion that can open the closed doors that we faced to the next 
generation(s). Special sections have been devoted to spatial as well as temporal 
heterogeneity of the cardiac action potential. Genetic heterogeneity and allelic 
heterogeneity are two prominent findings of channelopathies that confirm the 
fact of the major overlap in the field. The way we present the clinical findings is a 
true call for the next generation(s) of clinicians and researchers to revolutionize 
the field in the near future. Detailed management plans based on the up to date 
basic sciences findings for the different channelopathies give better therapeutic 
options for the clinicians in the field. Unique to this chapter is the new directions 
to look for channelopathies beyond the human body. The new understanding 
of the psychophysiological well-being of HRV and the sympathovagal balance 
extending to cosmic resonances and its possible effect on cardiac ion channels 
carries new era of promising preventive, diagnostic and therapeutic options.
Keywords: arrhythmia, Brugada syndrome (BrS), cardiac coherence (CC), 
catecholaminergic polymorphic ventricular tachycardia, ERS early repolarization 
syndrome, heart rate variability, long QT syndrome (LQTS), progressive cardiac 
conduction disease, sudden cardiac death, Schumann resonance, solar geomagnetic 
activity, SNP, SQTS
1. Introduction
One of the most devastating life moments that may impact the whole life 
of a person, family and society is sudden death experience of close relative or 
beloved. The whole medical provision is dedicated to prevent or delay death while 
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maintaining good quality of life (QOL). For this reason, sudden loss of human life is 
creating the most serious challenge for medical professionals and decision-makers.
Sudden cardiac death (SCD) is defined as death occurring unexpectedly in the 
first hour after symptoms commence [1]. In the United States, around 300,000 deaths 
are occurring every year because of SCD [2]. It is conspicuous that this huge loss in 
the world communities is creating a major social impact. This impact is undoubtedly 
more destructive with the loss of young member of the family [3]. Ion channels in 
the myocardial cellular membrane are responsible for creating the basic unit of the 
electromagnetic foundation in humans known as cardiac action potential (AP). This 
is the result of an elegant interplay of ions at the cellular level. Genetic mutations in 
these channels can predispose to wide spectrum of clinical presentations and syn-
dromes referred collectively to channelopathies (ionopathies). The basic pathology 
is genetic mutations creating disturbance in the process of critical ions traffic (Na+, 
Ca2+, K+) across the cell membrane. The delicate miraculous balance in this ion traffic 
is the basic unit of the normal action potential. Disturbance of this balance in terms of 
loss or gain of function is the source of the fatal heart rhythm. Sadly, life-threatening 
arrhythmias and sudden cardiac death can be the first presenting symptom. Scientists 
and clinicians are racing in the last two decades in a unique complementary scientific 
effort to reconcile the rapidly growing body of knowledge of the molecular mecha-
nisms and clinical correlates of SCD. In this chapter, we will review the epidemiol-
ogy of the sudden cardiac death (SCD), then we will discuss the basic science of 
cellular action potential and its anomalies. We will navigate in detail in the genetic 
characterization of arrhythmic phenotypes, which started in 1995 with discovery of 
LQTS mutations, and the subsequent characterization of the diversity of genetic and 
molecular derangements, which can lead to channelopathies and the fatal rhythms.
2. Epidemiology of sudden cardiac death
Incidence and prevalence calculation in any disease in medicine is inevitably under-
estimation of the actual figures. This is due to the fact that underdiagnosis is the role. 
The most common cause of sudden death (SD) is SCD. Sudden cardiac death (SCD) is 
defined as sudden death within 1 h of the appearance of witnessed symptom or within 
24 h of unwitnessed symptom in an individual without potentially lethal diagnosis [1].
Many cases of SCD have identifiable abnormalities such as hypertrophic car-
diomyopathy, arrhythmogenic right ventricular cardiomyopathy, coronary artery 
anomalies or myocarditis [4]. However, a significant proportion of SD (3–53%) has 
no identifiable cause on autopsy examination, and these are labelled sudden unex-
pected death (SUD). Cardiac channelopathies (used interchangeably with ionopathy) 
account for approximately one-third of SUD cases. Worldwide records demonstrated 
that around 3,700,000 death per annum are due to SCD. In the western world (the 
United States and Europe), 1–2 death per 2000 of the general population are lost due 
to SCD. SCD in male gender is 3 times higher than female [2]. Channelopathies such 
as long QT syndrome (LQTS), Brugada syndrome (BrS), catecholaminergic polymor-
phic ventricular tachycardia (CPVT), short QT syndrome (SQTS), early repolariza-
tion syndrome (ERS) and idiopathic VF are estimated to be responsible for 10% of 
SCDs [5]. It is believed that about one-third of SUD cases are due to channelopathies.
2.1 Epidemiology of channelopathies
2.1.1 Long QT syndrome
Long QT syndrome (LQTS) is an inherited genetically heterogeneous group of 
arrhythmias characterized by a prolonged QTc interval in the 12-lead ECGs  
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(with QTc values >470 ms for males and >480 ms for females, representing approxi-
mate 99th percentile values). The prevalence of LQTS in what seems to be healthy 
live births in Italy is 1:2500 [6]. In New Zealand, the reported prevalence is 1:4500 
[7]. In Korean males, they reported QT prolongation (equal or more than 460 ms) 
as 1:5000 [8]. In Japanese males with high likelihood of LQTS score >3.5, the preva-
lence was similar to Italy (approximately 1:2500) [9].
In conclusion, the Asian reported prevalence is comparable to the west (1:5000–
1:2500). At least 17 genes were identified contributing to LQTS. Mutations have 
been found in more than half of them (40–70%) [10]. In spite of the complexity of 
the subject, clinicians need to know for their practice more than 75% of mutations 
in congenital LQTS are located in the KCNQ1 (LQT1), KCNH2 (LQT2) or SCN5A 
(LQT3) genes [10]. The prevalence of the different gene mutations for LQT1, LQT2, 
LQT3 and others is 52%, 33%, 7% and 1.2%, respectively. A Japanese survey of 41 
individuals reported genotypes in 71% constituting LQT1 38%, LQT2 38%, LQT3 
21% and LQT8 3% [11]. The International LQTS Registry documented cardiac 
events (syncope, cardiac arrest and SCD) in LQTS individuals to be 63% for LQT1, 
46% for LQT2 and 18% for LQT3 [12]. Cardiac events in LQT3, although being 
the less frequent, were shown to be more lethal than the other two types [12]. The 
triggers of the different LQTS are of special diagnostic indication. LQT1 is known 
to be triggered by exercise (typically swimming), while LQT2 has been linked to 
emotional events, like startle (typically alarm clocks) and delivery [13]. LQT3 is the 
‘inevitable’ as it occurs during periods of rest or sleep. During childhood, boys with 
LQTS tends to develop more fatal attacks, compared to girls. After childhood, the 
incidence is comparable [14].
2.1.2 Short QT syndrome (SQTS)
SQTS was described in 2000, and it is a clinical entity characterized by short 
QT intervals on ECG (generally, QTc < 350 ms), high incidence of VT/VF, absence 
of structural heart disease, familial history of SCD and resuscitated cardiac arrest 
[15]. It is the severest form of the major channelopathies, with cardiac arrest/SCD 
being the most common presentation. Events occur during rest, sleep or exertion 
[4]. For this reason, high index of suspicion should be practiced in order to be able 
to diagnose this type of malignant channelopathies. Among 10,984 Japanese with 
approximately equal sex distribution, 1:3400 individuals showed QTc less than 
300 ms [16]. Parts of idiopathic VF cases are likely to be borderline or latent SQTS 
individuals. SQTS was diagnosed in 12% of idiopathic VF survivors [17]. The course 
of SQTS individuals is more malignant with higher risk of recurrence of life-threat-
ening arrhythmias and SCDs [18].
2.1.3 Brugada syndrome (BrS)
There is general impression that BrS incidence is underestimated. In one pub-
lication, BrS accounts for 4–12% of SCD [4]. It appears to be related to mutations 
affecting Na+ channels. There are currently more than 300 mutations described, 
mostly autosomal dominant, affecting the SCN5A gene, leading to loss of Na+ 
channel function in a variety of ways (interestingly, mutations in other parts of 
this gene lead to LQTS3). Other genes affecting the Na+ channel are also implicated 
in BrS. BrS is characterized electrocardiographically by classical finding of coved 
ST-segment elevation in anterior precordial leads. Cardiac events secondary to 
ventricular tachycardia typically occur in young adults but have been described in 
children and infants [4]. Individuals with BrS develop a monomorphic ventricular 
tachycardia; often precipitated during sleep or rest, and during febrile illnesses [19]. 
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It is thought that some SCN5A mutations alter the Na+ channel in a temperature-
dependent manner. Males have arrhythmic events more frequently, and there is 
thought to be a gender effect on ion channel expression [20]. The estimated preva-
lence of BrS ranges from 0.02 to 0.1% in Europe and from 0.1 to 0.25% in Asia [5]. 
Lai Tai means the southern pattern (referring to the mode of death during sleep) is a 
famous horror term in Thailand and ‘Pokkuri’. The death secret has been diagnosed 
as Brugada syndrome, which is thought to be endemic heart electrical disease in 
this part of the world [21]. Later on, Europeans were shown to have similar preva-
lence [5]. About one-third of cases have been attributed to SCN5A mutations [22]. 
Mutations attributed to CACNA1C and CACNB2 are seen in around 12% of cases. 
Minor percentages are due to other gene mutations like GPD1L, SCN1B, KCNE3 
and SCN3B [23–27]. In 50–80% of patients with BrS, VF or VT can be induced by 
ventricular extra stimuli in an EPS. There is dispersion of opinions in the ionopathy 
literature regarding the prognostic value of VT/VF inducibility in EPS. Nobuyuki 
Murakoshi and colleague consider inducibility as a poor prognostic factor, while 
many other authors do not believe of any significant correlation [5].
2.1.4 Early repolarization syndrome (ERS)
ERS is characterized by elevation of the QRS-ST junction (J point) and QRS 
notching or slurring (J wave) in multiple leads, especially the inferior and/or left 
precordial leads [28]. The slurred J point elevation which was interpreted by cardi-
ology communities as normal electrocardiographic variant distracted Haissaguerre 
et al. who reported very important observation in this regard. Among 207 victims 
of idiopathic VF, 30% were found to have the slurred J point pattern (ER pattern) 
compared to 5% of controls [29].
In the Framingham Heart Study, the ER pattern was found in 6.1% of American 
and European persons and 5.8% in Finnish population [30, 31]. In Asia, the story 
seems to be more impressive. J wave elevation of at least 0.05 mV was detected in 
7.26% of Chinese subjects [32]. In Japan, the incidence rate was 715 per 100,000 
person-years [33].
In general, reviewing todays medical literature will reveal ERS prevalence fig-
ures which range from approximately 6 to 13% in the general population [34]. Male 
sex, younger age, lower systolic blood pressure, higher Sokolow-Lyon index for LVH 
calculation (S in V1 + R in V5 or V6 (whichever is larger) ≥ 35 mm (≥7 large squares) 
or R in aVL ≥ 11 mm) and lower Cornell voltage (S in V3 + R in aVL > 28 mm (men) 
or S in V3 + R in aVL > 20 mm (women)) are independently associated with the 
presence of the ER pattern [30]. An important observation in that regard points to 
the proportionality of ER amplitude to the risk of arrhythmic death.
ER of 0.2 mV or more in ECG inferior leads was shown to have much increased 
risk than those without. This was concluded after long mean follow-up of 
29–41 years [35]. Notching of the J point was found to be associated with worse 
prognosis [5]. The rapid rise of ST segment and dominance of ST pattern in athletes 
was found to be benign variant of ERS. Looking with eye of scrutiny will show 
the similarities of clinical, electrocardiographic and genetic aspects between BrS 
and ERS. Future research could prove both syndromes to be a spectrum of one 
pathology.
2.1.5 Catecholaminergic polymorphic ventricular tachycardia (CPVT)
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited 
arrhythmogenic disorder characterized by polymorphic VT induced by physical 
or emotional stress without any detectable morphological abnormalities in the 
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heart [36]. Two important gene mutations has been described: mutations in genes 
encoding cardiac ryanodine type 2 receptor (RYR2) [autosomal dominant] and 
calsequestrin 2 (CASQ2) [autosomal recessive] [37, 38]. A subunit for inward-
rectifier potassium channels called Kir2.1. Mutation in this subunit (KCNJ2) is 
responsible of a third variant of CPVT [39]. A Japanese report of 50 cases ranks 
the CPVT mutations frequency as follows: RYR2 (56%), CASQ (22%) and KCNJ2 
(22%) [40]. CPVT is gaining more attention although being a rare disease com-
pared to other channelopathies (1:10,000) because of its tendency to affect chil-
dren and young adults [41]. In fact, CPVT is considered as highly malignant heart 
rhythm if neglected. In those situations, by the age of 20–30 years, the mortality is 
30–50% [42].
2.1.6 Heart channelopathies and systemic involvement
Action potential is the basic unit of human body electricity. It is conceivable 
that ionopathic involvement of other systems is a fact. This will result in symptoms 
and syndromes that deserve attention for proper risk stratification of ionopathic 
subjects. Behere and Weindling elaborated on this in their unique review [43].
Jervell and Lange-Nielsen syndrome (JLNS) has been associated with about 
4% of patients with the bilateral sensorineural loss [44]. However, Chang et al. 
challenged this concept. They thought that this association may have been over-
estimated in the era before genetic testing, and newer studies seem to reflect the 
similar rate of LQTS causing mutations in deaf children, as in the general popula-
tion [45]. There is overlap between seizure disorders and cardiac channelopathies. 
Sudden unexpected death in epilepsy (SUDEP) has an incidence of 6–9/1000 
person-years in epilepsy surgery programs. Channelopathy-associated mutations 
have been identified in 13% of patients with SUDEP [46]. Seizures triggered by 
exercise, emotion, sudden stimuli, seizures unresponsive to anti-seizure medica-
tions and seizures in the setting of family history of SD, syncope or obvious 
electrocardiographic abnormalities should all be viewed with high index of suspi-
cion for underlying channelopathy [47]. In patients with BrS, fever is a well-known 
arrhythmogenic trigger because SCN5A mutations alter the temperature sensitivity 
of fast inactivation of the Na+ channel. This may cause ‘apparent life-threatening 
events (ALTEs)’ and even SUD or sudden infant death syndrome (SIDS) in suscep-
tible infants in the setting of febrile illnesses [48]. As many as 30% of victims of 
drowning-related deaths have been found to have cardiac channelopathies [49, 50]. 
Patients with SCN5A mutations have been found to have irritable bowel syndrome 
(IBS). In a recent study, 2% of patients with IBS were found to have SCN5A muta-
tions, and in one case, mexiletine administration even caused normalization of 
bowel habits. It is hypothesized that channelopathies are involved in the patho-
genesis of some forms of IBS [51]. There is also a co-existence of iron-deficiency 
anaemia, hypergastrinemia and gastric hyperplasia associated with LQT1. This 
suggests not only a role for the gene KCNQ1 in gastric secretion but also a role for 
gastrin as a marker of arrhythmia severity [52, 53]. Interestingly, in a study from 
the United States, 36% of patients with drug-induced LQTS possessed known 
arrhythmia-associated mutations [54].
2.1.7 Cardiac channelopathies and sudden infant death syndrome (SIDS)
SIDS is defined as SD of seemingly healthy children of age <1 year. The incidence 
of SIDS varies across the world [54]. About 10–20% of SIDS cases are attributed to 
genetic mutations associated with channelopathies [19, 54, 55]. Mutations associ-
ated with LQTS1 and LQTS3 have been related to SIDS [54]. Mutations in the 
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genes encoding the beta sub-units of Na channels have also been implicated [56]. 
Interestingly, a loss of function mutation in the K+ channel encoding gene KCNJ8 has 
also been associated with SIDS. It is hypothesized that this mutation causes maladapta-
tion to stress such as endotoxemia [55]. A Japanese study looking more broadly at the 
characteristics of all infantile LQTS found that 84% of all cases were diagnosed in 
the foetal or neonatal period. LQTS1 was associated with most risk of a first cardiac 
event, but LQTS2 and LQTS3 more exclusively caused VT or TdP [11]. QT intervals 
were found to be longest around 2 months of age [57]. Foetal magnetocardiography 
and echocardiography have been used to assess foetal LQTS. Sinus bradycardia is a 
common finding. Trans-placental magnesium and lidocaine, and prenatal beta-blocker 
therapies have been used for management [58]. While less commonly studied or iden-
tified, mutations associated with CPVT, SQTS, and BS have been linked to SIDS [54].
3.  The basic electrophysiology of the myocyte and myocardium in ion 
channel disease
Basic understanding of the electrophysiology of cardiac cells action potential 
(AP) and its anomalies constitutes the corner stone to dive and disclose the secrets 
of ionopathies and the resultant fatal cardiac rhythm. Basic research uses molecular 
techniques, as well as animal models. Phases of the ventricular action potential with 
description of major events (Figure 1) proved extremely useful in improving the 
arrhythmia communities’ knowledge of inherited arrhythmogenic syndromes. The 
discussion of the myocyte action potential is invariably the discussion of the ion 
channels of the cellular membrane since the delicate trans-membrane traffic of ions 
is the source of cardiac action potential during normal electrophysiological function 
of the heart. It is critical to perceive that abnormal heart rhythms including the fatal 
ventricular arrhythmias are primarily due to abnormal formation or mutations of 
those trans-membrane pores or its regulatory subunits. Mutations in any of the genes 
involved in regulation of cardiac ion channels may potentially result in arrhythmias 
and may be classified as arising from either abnormal AP formation or abnormal AP 
propagation. Martin CA et al. authored unique review in this regard [59].
3.1 Abnormal AP formation and propagation
Aberrancy of AP formation can be interpreted through three main mechanisms: 
reentry, triggered activity or automaticity. Acceleration of depolarization of 
pacemaker tissue will end up with autonomous formation of AP called enhanced 
automaticity. This can be precipitated by underlying sympathovagal imbalance 
in favour of excessive sympathetic tone, hypokalaemia or drugs such as digitalis. 
Triggered activity referred to extra systole generated outside the primary pace-
maker tissue [59]. The underlying mechanism is called afterdepolarization, which 
is oscillations of cardiac cell membrane potential generated before the previous 
AP, ending up with premature new AP. If this premature AP magnitude is reaching 
threshold, it will produce triggered beat. According to the timing of this triggered 
activity, it can be early or late. Triggered activity during repolarization of the 
original AP is called early afterdepolarization (EAD). It occurs when AP dura-
tion is prolonged until a degree where L-type Ca2+ channels are recovered from 
inactivation during the time of membrane depolarization. Inward ICa-L current 
will initiate the new premature depolarization of the membrane and will initiate 
the afterdepolarization [60]. Triggered activity after completion of repolarization 
or near completion is called delayed afterdepolarization (DAD). It occurs due to 
enhanced Ca2+ release from the cellular calcium store organelle called sarcoplasmic 
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reticulum (SR) due to either activation of the Na+/Ca2+ exchanger or Ca2+-activated 
Cl-current. Classical examples of this Ca2+ overload environment is during digitalis 
toxicity or Catecholaminergic Polymorphic VT [61] (Figure 2A). The reentrant 
mechanism is unique. It requires an electrical obstacle around which AP is able to 
go around, disproportionately conducting exit pathways, one conducting fast and 
the other conducting slow and finally unidirectional conduction block. It is the 
most important mechanism as it is widely spread in much pathologies and most 
importantly the only type that is amenable for study and ablation in electrophysiol-
ogy laboratory. The most common arrhythmias in clinical electrophysiology like 
atrioventricular nodal reentry tachycardia (AVNRT) and atrioventricular reentrant 
tachycardia (AVRT) are both reentrant and amenable for ablation. It is the underly-
ing mechanism in patients with ventricular scarring, usually from old myocardial 
infarction, cardiomyopathy and infiltrative disease (Figure 2B).
3.2 Spatial electrophysiological heterogeneity
The human heart has been created in miraculous way where the structure sup-
ports and complements the function. After initiation of the normal impulse in the 
Figure 1. 
Phases of the ventricular action potential with description of major events [59].
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sinus node, the wave of action potentials is characterized by highly sophisticated 
levels of gradients of depolarization and repolarizations, to maintain the normal 
electro-mechanical activation sequence for the pumping heart functions. The 
dominant determiner of these spatial gradients is the regional differences in repo-
larizing K+ channels. These include channel density variations, kinetics and cycling 
traffic between membrane and cytoplasm. The substrate for reentry is created by 
disturbances in these gradients, which may permit depolarized regions to reexcite 
polarized areas [59]. Transmural gradients alterations correlated with arrhythmo-
genic tendencies in a number of both pharmacological canine and genetic murine 
models for LQTS and BrS. The reexcitation may occur when the epicardial action 
potential duration is much shorter than the endocardial, potentially leading to new 
AP (Figure 2C).
This new environment of electrical dispersion within the cardiac tissue was 
proved to be arrhythmogenic in cardiomyopathies. This spatial heterogeneity was 
linked to T wave alternans (TWA) and ventricular tachycardia [62]. Reentry created 
by epicardial dispersion of repolarization was seen to be the trigger for ventricular 
tachycardia in preparation of canine right ventricular wedge [63] and the Scn5a+/− 
mouse model [64]. Source of arrhythmia in Brugada syndrome is thought to be 
secondary to AP duration differences between left ventricle and right ventricle. This 
is reflected in Brugada patients as ST elevation in right precordial leads and right 
epicardial AP changes [65].
Figure 2. 
Different mechanisms of arrhythmias [59]: (A) triggered activity: early after depolarization (EAD) (upper 
trace) and delayed after depolarization (DAD) (lower trace). Dotted lines represent formation of new AP.  
(B) Reentrant circuit: normal impulse propagation in two equal conduction velocities with collision in the 
middle and termination of the impulse (upper diagram). Presence of slow limb in the circuit (solid line) 
will end up with the normal impulse pass through and circulates around the other limb which is the fast limb 
at a time where its refractoriness is over (dotted). This will end up with excitation of the myocardium and 
initiation of tachycardia (lower diagram). (C) Transmural gradients due to heterogeneity of AP in different 
locations: shorter AP in epicardium compared to endocardium will end up with reexcitation. (D) Heterogenity 
of AP timing: creating duration alternans with the result of nodal line when the alternans time out creating 
block predisposing to reentry in the presence of triggered impulse.
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3.3 Temporal electrophysiological heterogeneity
Electrical dispersion may also affect activation sequence. Temporal beat-to-beat 
variation in the AP amplitude or duration, a phenomenon known as alternant 
(Figure 2D), has been associated with arrhythmogenesis in both clinical and 
experimental studies [66, 67]. This can have significant consequences on the spatial 
organization of repolarization across the ventricle, amplifying the heterogeneities 
of repolarization present at baseline into pathophysiological heterogeneities of 
sufficient magnitude to produce conduction block and reentrant excitation. Regions 
which alternate out of phase generate a line of block called the nodal line between 
them. This has the potential to act as a focus for reentrant circuits following the 
addition of a triggered beat.
3.4 The channelopathies
3.4.1 Long QT syndromes
LQTS constitute a group of genetic disorders distinguished by long QT interval 
in the electrocardiogram, representing prolongation of repolarization period asso-
ciated with the risk of ventricular arrhythmias (in specific torsade de point) and 
sudden death. In comparison to Brugada syndrome, the genetic mutations in LQTS 
result in tendency for electrical disturbance, affecting depolarization rather than 
repolarization. An arrhythmic substrate with prolonged AP duration was implicated 
in several mouse models [68] (Figure 3). Functional block pockets are created by 
prolonged depolarization phase  during which the impulse pathway will be refrac-
tory. This functional block will create reentry focus and myocardial excitation. In 
addition, repolarization potentials dispersion across the myocardium will provide 
a functional reentry pathway facilitating initiation of torsade de point. Prolonged 
depolarization may result in EAD with consequent polymorphic VT. Data from 
transgenic rabbits [69], have recently been instrumental to support a novel view 
on the arrhythmogenesis in LQTS by Chang et al. [70]. These authors developed an 
in silico model (i.e. computational modelling, simulation and visualization of the 
cardiomyocyte electrophysiological behaviour and arrhythmogenesis in a virtual 
computerized environment) of prolonged repolarization. They were able to dem-
onstrate that arrhythmogenesis is initiated by two types of spiral waves: short cycle 
and long cycle. The short cycle is mediated through INa (Figure 4A) and the long 
cycle is mediated through slow L-type calcium current (ICa) (Figure 4B) [70]. The 
alteration of those two types of waves gives what resemble torsade de point in the 
ECG. Arrhythmogenesis in LQT1 was investigated by Kim et al. using transgenic 
rabbit models. Multiple EAD foci were demonstrated as well as AP bimodal distri-
bution compatible with the concept of two excitation types [70].
3.4.2 Brugada syndrome (BrS)
BrS is clearly distinguished between other channelopathies with its electrocar-
diographic manifestation in the form of delayed right ventricular activation with 
posterior T wave manifested mainly in V1 and V2. Clinically it is characterized by 
episodic history of poly morphic VT and ventricular fibrillation (VF) [59]. Genetic 
heterogeneity is a hall mark feature of BrS where multiple genetic mutations result in 
the same phenotype. All mutations end up with imbalance of the currents favouring 
repolarization over depolarization (in contrast to LQTS). The most famous BrS muta-
tion is the SCN5A gene where there is loss of function encoding the alpha subunit of 
the Na+ voltage-gated channel. INa reduction seems to be the underlying mechanism. 
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Experimental studies using canine hearts as well as clinical studies support this 
pathophysiological mechanism underlying BrS [71, 72]. Reduction of Na+ current can 
impose its effect represented by the deep notch of phase 1 of the epicedial AP, which 
is most impressive in RV. This reduction in Na+ current creates voltage gradient across 
RV. This state of electrical imbalance in RV epicardium facilitates participation of the 
proximal myocardium to reactivate RV, ending up with reentry. This type of reentry is 
called phase 2 reentry (Figure 5). Another perspective to interpret the ECG manifes-
tations of BrS is based on right ventricular out flow (RVOT) conduction delay per-
spective [73]. This perspective was derived from echocardiographic measurements, 
signal-averaged ECG (SAECG) potentials and mapping of body surface [74, 75]. 
An ex vivo experiment demonstrating RVOT conduction delay was published [76]. 
Fractionated late potentials that was amenable for catheter ablation was documented 
in the anterior aspect of RVOT epicardium. This specific site ablation normalized ECG 
and prevented VT and VF associated with BrS [77].
3.4.3 Catecholaminergic polymorphic ventricular tachycardia (CPVT)
Surge of catecholamines due to stress or exercise is the substrate fuel of bidi-
rectional VT leading to syncope or SCD. This is creating an important category 
Figure 3. 
LQTS mechanistic representation of arrhythmogenesis as understood from animal model. Scales showed 
genetic mutations can give rise to either gain of depolarization currents or loss of repolarization currents. EAD 
(triggered activity) will result as well as transmural gradients and refractory pockets formation. The clinical 
outcome as seen in ECG is represented by the trace at the bottom of the graph (torsade de pointes) [59].
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of channelopathies called CPVT. At cellular level, enhanced Ca2+ release from the 
cellular calcium store organelle called sarcoplasmic reticulum (SR) is the operating 
mechanism. This enhanced Ca2+ release is due to gain of function gene mutation 
encoding ryanodine receptor 2 (RyR2), which is an important regulator of Ca2+ 
release for myocardial cells excitation contraction coupling [78]. The other impor-
tant gene mutation results in loss of function affecting calsequestrin (CASQ2) pro-
tein, which is in normal situations functioning as SR calcium buffering protein [79]. 
This Ca+ release affects AP in a way favouring DAD as in digitalis toxicity concluded 
in arrhythmic trigger [36] (Figure 6). A net inward current is generated secondary 
to cytosolic Ca+ overload in vitro studies with RyR2 and CASQ2 mutations [61, 80]. 
RyR2 [81] or in CASQ2 [82] genes deliberately inserted into transgenic animals 
(mouse in this situation) revealed abnormal Ca+ transients and bidirectional 
VT. This level of evidence is supporting the idea that inward current might be the 
underlying mechanism of DAD triggering the abnormal beat. RYR2 mutations have 
also been suggested to be associated with dilated cardiomyopathy [83], hypertrophic 
cardiomyopathy [84] and arrhythmogenic right ventricular cardiomyopathy [85].
3.4.4 Other syndromes
While a majority of cases of SCD in the absence of structural heart abnormali-
ties are caused by LQTS, BrS and CVVT, other less common syndromes are of 
Figure 4. 
In silico cardiac tissue model of prolonged repolarization. Arrhythmogenesis is initiated by two types of spiral 
waves: short cycle and long cycle. The short cycle is mediated through INa (A) and the long cycle is mediated 
through slow L-type calcium current (ICa) (B) [70].
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importance. Short AP and accordingly QT intervals in short QT syndrome (SQTS) 
is due to mutations causing gain of function handling K+ channels [86] or mutations 
causing loss of function handling Ca+ channels [87]. An increase in repolarization 
gradients was seen to be the underlying mechanism [88]. In early repolarization 
syndrome (ERS), J point elevation with prominent T wave is seen (early repolariza-
tion pattern). This electrocardiographic pattern is associated clinically with VT 
and sudden death [89]. The exact mechanism is still obscure although AP early 
phase increment in transmural gradients has been suggested in canines hearts [90]. 
Rarely, reduction in inward Ca+ current [91] or increment in outward K+ cur-
rent mutations [92] has been described, although a majority of cases lack genetic 
mutations. The weight of evidence nowadays is supporting that the ER pattern is 
polygenic with an important contribution of epigenetic and environmental factors.
Figure 5. 
Brugada syndrome’s mechanistic representation of arrhythmogenesis as understood from animal model. Scales 
showed genetic mutations can give rise to either loss of depolarization currents or gain of repolarization 
currents. The ultimate outcome of those AP changes is more likelihood for alternans and phase 2 reentry. The 
clinical outcome as seen in ECG is represented by the trace at the bottom of the graph (polymorphic VT) [59].
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Progressive cardiac conduction disease (PCCD) also known as Lenegre’s disease 
is a rare progressive degenerative disease of the cardiac conduction system with 
autosomal dominant pattern of inheritance that may end up with widening of QRS 
complexes, long pauses and bradycardia. It is a cause of SCD. The first gene muta-
tion of PCCD described was SCN5A. This mutation can be associated with complex 
phenotype of PCCD, Brs and LQT3, sometimes referred as (overlap syndrome) 
[93]. Recently, PCCD was seen as an association with altered expressions of other 
gene proteins encoding impulse propagation like Ca+-activated ion channel and 
cytoskeletal components. The conclusive phenotype as seen in mouse experiments 
is thought to be an additive effect of genetic components with environmental modi-
fiers and aging [94].
4. Summary
SCD is extreme, devastating and traumatic life event. Inherited ventricular 
arrhythmias, which is due to disturbed ionic traffic across cardiac cell membrane 
(channelopathy), comprised 1/3 of all cases of SUD and 10% of SCD as a whole. 
Channelopathies occupies strategic location in the basic science as well as clini-
cal and research arenas due to its recalcitrant behaviour and complexity. The 
discoveries of the genetic mutations of channelopathies heralded in 1995 have 
Figure 6. 
CPVT mechanistic representation of arrhythmogenesis as understood from animal model. DAD-triggered 
activity is due to genetic mutation causing rise in cytosolic Ca+ which in turn will result in depolarization 
current obeying the electrogenic nature of the Na+/Ca2+ exchanger. The clinical outcome as seen in ECG is 
represented by the trace at the bottom of the graph (bidirectional VT) [59].
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expanded drastically, resulting in revolutionary understanding of the disease. 
The most important described channelopathies up to date are long QT syndromes 
(LQTS), Brugada syndrome (BrS), catecholaminergic polymorphic ventricular 
tachycardia (CPVT), short QT syndrome (SQTS), early repolarization syndrome 
(ERS) and idiopathic VF. New disease entities are expected to be discovered in the 
near future. LQTS is an inherited genetically heterogeneous group of arrhythmias 
characterized by a prolonged QTc interval in the 12-lead ECGs (with QTc values 
>470 ms for males and >480 ms for females, representing approximate 99th 
percentile values). LQTSs as a whole occurs in 1:2500 of the general population. 
At least 17 genes were identified contributing to LQTSs with mutations positive 
in about half of the affected individuals. The incidence of LQTSs in decreasing 
frequency illustrates LQT1 as the commonest (35%) followed by LQT2 (30%) 
and then LQT3 (10%). The least frequent but most lethal and more difficult to 
manage is LQT3. Other rare types of LQTSs account for less than 1%. It seems 
that the normal range of QTc interval is critical for normal AP and normal heart 
rhythm. Prolongation or shortening of QTc interval is arrhythmogenic. Short QT 
syndrome with QTc < 350 ms (reported in 1:3400) is etiologically proven cause 
of malignant VT and VF. Brugada syndrome diagnosed as coved ST-segment 
elevation in anterior precordial leads occurs in approximately 0.02% up to 0.20% 
in general population. It overlaps with some of the genetic and clinical features 
of LQT3. Catecholaminergic polymorphic ventricular tachycardia (CPVT) is 
relatively a rarely inherited arrhythmogenic disorder (1;10,000) characterized by 
polymorphic VT induced by physical or emotional stress without any detectable 
morphological abnormalities in the heart. The most important mutations causing 
CPVT are in genes encoding cardiac ryanodine type 2 receptor (RYR2) [autosomal 
dominant] and calsequestrin 2 (CASQ2) [autosomal recessive]. It is considered as 
highly malignant heart rhythm if neglected. ERS is characterized by elevation of 
the QRS-ST junction (J point) and QRS notching or slurring (J wave) in multiple 
leads, especially the inferior and/or left precordial leads. It seems to be more 
frequent than ever thought with ranges from approximately 6–13% in the general 
population. Approaching channelopathies in its broad spectrum is an excellent 
example of the demand of system biology approach in medicine. Channelopathies 
involving the heart may overlap with manifestations in the nervous system, 
gastrointestinal system, hearing, infant death syndrome and others. Fatal ven-
tricular arrhythmias are due primarily to abnormal formation or mutations of 
trans-membrane pores or its regulatory subunits. Aberrancy of cardiac action 
potential (AP) formation can be interpreted through three main mechanisms: 
reentry, triggered activity or automaticity. All the different mechanisms described 
will end up with anomalous action potential. Spatial as well as temporal electro-
physiological heterogeneity are important basic electrophysiological derangements 
that underline cardiac action potential anomalies. Heterogeneity of AP in time and 
location between myocardium and epicardium are critical predisposing factors to 
the fatal cardiac rhythm. In comparison to Brugada syndrome, the genetic muta-
tions in LQTS result in tendency for electrical disturbance affecting depolarization 
rather than repolarization. Surge of catecholamines due to stress or exercise is 
the substrate fuel of bidirectional VT leading to syncope or SCD in CPVT. RYR2 
mutations have also been suggested to be associated with dilated cardiomyopathy, 
hypertrophic cardiomyopathy and arrhythmogenic right ventricular cardiomy-
opathy. ER pattern is thought to be polygenic with an important contribution of 
epigenetic and environmental factors. Advances in our knowledge and under-
standing of disease epidemiology and the basic electrophysiological derangements 
of channelopathies are intelligent directions that should guide all diagnostic and 
therapeutic approaches.
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